Picture of BioElectronics logo

BIEL BioElectronics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual cashflow statement for BioElectronics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.12-2.99-2.33-1.16-0.29
Depreciation
Non-Cash Items0.8061.090.9590.4160.249
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4410.540.650.216-0.279
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.869-1.35-0.716-0.528-0.32
Other Investing Cash Flow Items0
Other Investing Cash Flow
Cash from Investing Activities0
Financing Cash Flow Items-0.011-0.0440-0.132-0.112
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities0.8721.440.6690.5910.212
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0030.084-0.0470.063-0.109